Topics

Vertex Pharma Promotes Bozic as Kewalramani’s Successor

16:15 EDT 3 Oct 2019 | Xconomy

Vertex Pharmaceuticals (NASDAQ: VRTX) has appointed Carmen Bozic to serve as executive vice president of global medicines development and medical affairs. Bozic joined Boston-based Vertex earlier this year as senior vice president and head of global clinical development. Bozic will take on additional responsibilities as Vertex’s chief medical officer on April 1 when current CMO Reshma […]

Original Article: Vertex Pharma Promotes Bozic as Kewalramani’s Successor

NEXT ARTICLE

More From BioPortfolio on "Vertex Pharma Promotes Bozic as Kewalramani’s Successor"

Quick Search

Relevant Topic

BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...